- Lobbying
- Kristina AND Dunklin
Lobbying Arrangements Results for 'Kristina Dunklin'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 4394/S. 2443 - Energy and Water Development and Related Agencies Appropriations Act, 2024. Issues related to nuclear fusion and nuclear fission. |
General Atomics
|
Forbes-Tate | |||
Details Issues related to monoclonal antibody discovery, research and development. |
Genovac, LLC
|
Forbes-Tate | |||
Details Issues related to chemical manufacturing. |
Merck KGaA Darmstadt Germany
|
Forbes-Tate | |||
Details Issues related to Medicare. |
Contessa Health, Inc.
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical policy. |
Venatorx Pharmaceuticals
|
Forbes-Tate | |||
Details Issues related to grid modernization. |
Public Service Company of New Mexico
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical research and innovation. |
Revangenix
|
Forbes-Tate | |||
Details Issues related to Medicaid enrollment broker issues. |
Conduent Business Services, LLC
|
Forbes-Tate | |||
Details Issues related to primary and specialty care providers and telemedicine. |
Homeward Health
|
Forbes-Tate | |||
Details Issues regarding H2-B Visas; H.R. 3931/S. 2582 - Department of Homeland Security Appropriations Act, 2020. |
National Association of Landscape Professionals
|
Forbes-Tate | |||
Details Issues related to health products and technology for animals and aquaculture. |
Merck Animal Health
|
Forbes-Tate | |||
Details Issues related to kidney health and Medicare Advantage. |
Healthy.io (US), Inc.
|
Forbes-Tate | |||
Details Issues related to FDA approval and NIH funding issues. |
Sorrento Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical research, development and commercialization. |
Spero Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to innovations within the defense and intelligence satellite services. |
Orbital Effects
|
Forbes-Tate | |||
Details Issues related to H.R. 15/S. 5 - Equality Act, transgender rights, gender-affirming care. |
Human Rights Campaign
|
Forbes-Tate | |||
Details Issues related to medical education and research. |
Association of American Medical Colleges
|
Forbes-Tate | |||
Details Issues regarding "Medicare for All" related proposals. |
The Partnership for Americas Health Care Future
|
Forbes-Tate | |||
Details Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases. Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases; Issues related to new... |
Sarepta Therapeutics
|
Forbes-Tate | |||
Details Issues related to implementation of the Infrastructure Investment and Jobs Act (PL 117-58). Issues related to immigration reform. Issues related to FY 2024 Energy and Water Development appropriatio... |
Bipartisan Policy Center Action
|
Forbes-Tate | |||
Details Issues related to antitrust, competition, and the gaming industry. Monitor and advocate for operational improvements to S.1409 - Kids Online Safet Act. |
Sony Interactive Entertainment LLC
|
Forbes-Tate | |||
Details Issues regarding access to and reimbursement of proton therapy, including through Medicare and Medicare Advantage. Issues regarding access to proton therapy; Issues regarding the Radiation Oncology... |
National Association of Proton Therapy
|
Forbes-Tate | |||
Details Issues related to legislation to provide relief during the COVID-19 pandemic; Issues related to advanced research and development for COVID-19 response. Issues related to H.R. 925 - The Heroes Act. |
Bellerophon Therapeutics
|
Forbes-Tate | |||
Details Issues related to Operation WARP Speed, FDA, vaccine development and distribution. Issues related to Operation WARP Speed. |
Arcturus Therapeutics
|
Forbes-Tate | |||
Details Issues related to NIIT. |
GL Homes
|
Forbes-Tate | |||
Details Issues related to elections infrastructure funding. |
New Venture Fund on behalf of Center for Secure and Modern Elections
|
Forbes-Tate | |||
Details Issues related to tax preparation services. |
DS Admiral Bidco, LLC
|
Forbes-Tate | |||
Details Issues pertaining to the Federal Insecticide, Fungicide, and Rodenticide Act; Issues related to H.R. 7266 - To amend the Federal Insecticide, Fungicide, and Rodenticide Act to prohibit the local re... |
National Pest Management Association
|
Forbes-Tate | |||
Details Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169), specifically the hydrogen tax credit. |
NCCS
|
Forbes-Tate | |||
Details Issues related to natural gas pipelines, Issues related to permitting reform. Issues related to natural gas pipelines; Issues related to permitting reform; Issues related to Hydrogen tax credit. Is... |
The Williams Companies, Inc.
|
Forbes-Tate | |||
Details Issues related to accelerated use of AMT credits; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Research and Development tax credit; Is... |
T-Mobile
|
Forbes-Tate | |||
Details Issues related to corporate tax rates. Issues related to corporate tax initiatives. Issues related to the S.1260 - United States Innovation and Competition Act of 2021 and country-of-origin labelin... |
Target Corporation
|
Forbes-Tate | |||
Details Issues related to drug pricing; Issues related to 340b; Issues related to trade; Issues related to tax; Issues Related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). |
Bayer Corporation
|
Forbes-Tate | |||
Details Issues related to safety standards for ROVs. |
Recreational Off-Highway Vehicle Association, Inc.
|
Forbes-Tate | |||
Details Issues related to banking and consumer protection legislation. |
Activehours Inc., d/b/a Earnin
|
Forbes-Tate | |||
Details Energy Issues related to spent nuclear fuel policy, cybersecurity, and physical security; Issues related to permitting. Issues related to BLM. Interior Appropriations related to energy resiliency i... |
Pacific Gas and Electric
|
Forbes-Tate | |||
Details Issues related to Appropriations, COVID Relief Funds, HRSA. |
Storer Test Express DBA BusTest Express
|
Forbes-Tate | |||
Details Issues related to PFAS remediation. |
Regenesis
|
Forbes-Tate | |||
Details Issues related to transparency and accountability to ticket sales pricing. Issues related to transparency and accounting related to ticket sales pricing; Issues related to competition enforcement. ... |
Live Nation Entertainment, Inc.
|
Forbes-Tate | |||
Details Issues related to climate policy, transmission policy and workforce development; Issues related to transmission. Issues related to climate policy, transmission policy and workforce development; Iss... |
Exelon Corporation
|
Forbes-Tate | |||
Details Issues related to accelerated depreciation; Issues related to infrastructure deployment; Issues related to Research and Development Tax Credit. Issues related to spectrum auctions, net neutrality, ... |
Verizon Communications, Inc. and various subsidiaries
|
Forbes-Tate | |||
Details Issues related to clean energy tax credits; issues related to hydrogen and climate change; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pe... |
National Grid USA Service Company, Inc. D/B/A National Grid
|
Forbes-Tate | |||
Details Issues related to natural gas pipeline development and cybersecurity; Issues related to pipeline safety authorization, and general issues related to pipeline safety. |
Interstate Natural Gas Association of America
|
Forbes-Tate | |||
Details Issues related to taxation. Issues related to sports. |
National Hockey League
|
Forbes-Tate | |||
Details Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. |
Verde Technologies
|
Forbes-Tate | |||
Details Issues relevant to high speed flight and hypersonic. |
Hermeus Corporation
|
Forbes-Tate | |||
Details Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage and access in Medicare a... |
Gilead Sciences, Inc.
|
Forbes-Tate | |||
Details Issues related to flavors in Tobacco products; Conversations concerning federal appropriations policy related to FDA clarity on CBD; Issues related to FY2024 Ag-FDA Appropriations. Issues related t... |
Altria Client Services LLC
|
Forbes-Tate | |||
Details Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169). |
Halozyme Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to regulations that would restrict operations of farm bureau health insurance plans. |
Tennessee Rural Health Improvement Association
|
Forbes-Tate |